Enter your login e-mail to the account
Search
Search parameters
Search results
- Pharmacotherapy of rheumatoid arthritis II. – biological therapy
doc. MUDr. Želmíra Macejová, PhD., doc. MUDr. Ivan Rybár, PhD.
(2/2010, Drugs & drug classes ) - Systemic lupus erythematosus – an overview of new knowledge in pathogenesis, clinical picture and treatment
doc. Ing. Stanislava Blažíčková, PhD., prof. MUDr. Jozef Rovenský, DrSc., FRPC, MUDr. Ivana Stiborová
(2/2012, Review articles ) - Pharmacotherapy of inflammatory rheumatic diseases
PharmDr. Tatiana Geročová, PhD.
(6/2014, Interdisciplinary consilium ) - IMUNITNÍ SYSTÉM V PREVENCI A LÉČBĚ VIROVÝCH INFEKCÍ
MUDr. Karel Nouza, DrSc. , MUDr. Martin Nouza, CSc.
(10/2008, Consilium ) - Biologics for rheumatoid arthritis treatment
prof. MUDr. Juraj Payer, CSc., MUDr. Daniel Čierny, doc. MUDr. Zdenko Killinger, PhD., MUDr. Kristína Brázdilová
(9/2009, Review articles ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - DIFFUSE LARGE B-CELL LYMPHOMA
MUDr. Veronika Ballová
(12/2008, Topic ) - FOLLICULAR LYMPHOMA
MUDr. Adriana Kafková
(12/2008, Topic ) - CHRONIC LYMPHOCYTIC LEUKEMIA
prof. MUDr. Elena Tóthová, CSc.
(12/2008, Topic )
- New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - Experience with shortened ocrelizumab infusion – ENSEMBLE PLUS study
doc. MUDr. Yvonne Benešová, Ph.D.
(1/2022, Review articles ) - Pharmacotherapy of myastenia gravis
MUDr. Stanislav Voháňka, CSc., MBA
(2/2010, Main topic ) - Anti CD20 multiple sclerosis therapy
Doc. MUDr. Pavel Štourač, Ph.D.
(1/2018, Pharmacotherapy ) - Role of T and B cells in pathogenesis of multiple sclerosis
prof. RNDr. Jan Krejsek, CSc., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(2/2016, Review articles ) - Efficacy and safety of ocrelizumab in multiple sclerosis
MUDr. Radek Ampapa
(5/2017, Review articles ) - Long term efficacy of ocrelizumab on MRI parameters in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(1/2020, Review articles ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Multifokální motorická neuropatie
prof. MUDr. Josef Bednařík, CSc.
(1/2006, Main topic ) - High efficacy treatment since the first attack – an important step in the treatment of multiple sclerosis?
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(1/2023, Review articles ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - Ocrelizumab – pharmacoloical profile
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(5/2018, Pharmacotherapy ) - Cognitive impairment in selected systemic connective tissue diseases
MUDr. Jolana Marková , Mgr. Silvie Johanidesová, MUDr. Kateřina Storey, Ph.D.
(3/2016, Main topic ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Anti-NMDAr-panecefalitida – klinická kazuistika
MUDr. Michaela Tomečková, MUDr. Ondřej Horák, doc. MUDr. Hana Ošlejšková, Ph.D.
(2/2018, Case reports ) - Biological therapy by Ocrelizumab (antiCD20) is surprisingly clinically effective in multiple sclerosis patients
Prof. RNDr. Jan Krejsek, CSc.
(6/2017, From the boundary of neurology ) - Treatment of multiple sclerosis in Czech Republic – options and reality
MUDr. Michal Dufek
(1/2014, Review articles ) - Ofatumumab in clinical practice
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Treatment persistence to ocrelizumab and local experience
MUDr. Simona Halúsková, prof. MUDr. Martin Vališ, Ph.D., FEAN
(3/2021, Review articles ) - Efficacy and safety of ofatumumab in naive MS patients.
MUDr. Martina Martiníková
(5/2023, Informations ) - Ocrelizumab is dampening the harm inflammation in patients with multiple sclerosis with little impact on protective immunity
prof. RNDr. Jan Krejsek, CSc.
(3/2020, From the boundary of neurology ) - B lymfocyty v roztroušené skleróze mozkomíšní a postavení biologika cílícího na B lymfocyty v její léčbě
prof. RNDr. Jan Krejsek, CSc.
(3/2018, From the boundary of neurology ) - B cells as a target in the treatment of multiple sclerosis
MUDr. Luděk Hochmuth
(3/2017, Review articles ) - COVID-19 in patients with multiple sclerosis treated with ofatumumab
MUDr. Eva Recmanová
(2/2023, Review articles ) - Ocrelizumab – long-term efficacy and safety in real-world clinical practice in patients with relapsingremitting multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2022, Review articles ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic ) - Multifocal motor neuropathy
doc. MUDr. Peter Špalek, PhD.
(1/2016, Main topic ) - Paraproteinaemic neuropathies
prof. MUDr. Egon Kurča, PhD., MUDr. Monika Turčanová Koprušáková, PhD.
(1/2016, Main topic ) - B-cell targeted therapy to impact the progression of multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2023, Review articles ) - MS and NMOSD during the pandemic COVID-19 – what have we already learnt?
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(4/2021, Review articles ) - Biologics targeting CD20 molecule on B cells in the therapy of multiple sclerosis patients
Prof. RNDr. Jan Krejsek, CSc.
(6/2022, From the boundary of neurology ) - Ocrelizumab v léčbě roztroušené sklerózy
Prof. MUDr. Eva Kubala Havrdová, CSc.
(4/2017, Pharmacotherapy ) - B‑ lymphocyte‑ targeted MS therapy: from theory to a decade of ocrelizumab in practice
MUDr. Dominika Šťastná, Ph.D., MUDr. Jana Seňavová, prof. MUDr. Dana Horáková, Ph.D.
(2/2024, Review articles ) - Infl ammatory myopathies
doc. MUDr. Edvard Ehler, CSc. , doc. MUDr. Josef Zámečník, Ph.D.
(4/2012, Main topic ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles ) - Cranial neuropathy in a patient with Burkitt lymphoma infiltrating the cauda equina
MUDr. Eduard Minks, MUDr. Marta Pažourková, MUDr. Ivica Husárová, MUDr. Martin Pail
(2/2012, Case reports )
- Development of treatment of nephrotic syndrome in children
Prof. MUDr. László Kovács, DrSc., MPH
(1/2017, Review articles ) - Primary immunodeficiencies with predominantly antibody disorders
doc. MUDr. Peter Čižnár, CSc.
(5/2010, Review articles ) - Strukturální změny kostní dřeně prokázané pomocí celotělové magnetické rezonance jako časný projev akutní leukémie
prof. MUDr. Vladimír Mihál, CSc., MUDr. David Horák, MUDr. Dagmar Pospíšilová, Ph.D.,,MUDr. Jiří Bučil, Ph.D., doc. MUDr. Martin Tichý, CSc., MUDr. Kamila Michálková,; MUDr. Zbyněk Novák, MUDr. Jana Mathonová, prof. RNDr. Marie Jarošová, Ph.D.
(3/2005, Clinical-Radiological Diagnosis ) - ACTUAL TRENDS IN PREVENTION AND TREATMENT OF TYPE 1 DIABETES MELLITUS
MUDr. Stanislava Koloušková, CSc., MUDr. Pavla Mendlová
(4/2007, Review articles ) - When thrombocytopenia is not immune thrombocytopenic purpura
MUDr. Hana Flögelová, doc. MUDr. Dagmar Pospíšilová, Ph.D., MUDr. Lucie Sulovská, MUDr. Ivana Stejskalová, RNDr. Ingrid Hrachovinová
(6/2013, Case reports )
- Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - Lymphoma biologic therapy
MUDr. Andrej Vranovský, PhD.
(1/2011, Review articles ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - MALIGNANT LYMPHOMA DIAGNOSIS FROM THE PATHOLOGIST´S POINT OF VIEW
prof. MUDr. Lukáš Plank, CSc.
(2/2008, Review articles ) - HODGKIN’S LYMPHOMA
MUDr. Veronika Ballová
(2/2008, Review articles ) - TREATMENT STRATEGIES FOR CHILDHOOD NON-HODGKIN LYMPHOMA
h. doc. MUDr. Eva Bubanská, CSc.
(2/2008, Review articles ) - THE TREATMENT EFFECT EVALUATION OF MALIGNANT LYMPHOMAS
MUDr. Jan Hudeček, CSc., MUDr. Ivana Plameňová, MUDr. Juraj Chudej
(2/2008, Review articles ) - PRIMARY INTRACRANIAL HODGKIN LYMPHOMA IN 12-OLD YEAR BOY
MUDr. Viera Bajčiová, CSc.
(2/2008, Original articles ) - SPRÁVA Z LYMFÓMOVÉHO FÓRA 2008
MUDr. Adriana Kafková
(2/2008, Events ) - Primary breast lymphoma – rewiev and case reports
MUDr. Miriam Ladická
(1/2009, Original articles & case reports ) - Publikujeme v zahraničí
(3/2014, Information & comments ) - Treatment of localised and advanced diffuse large B-cell lymphoma
MUDr. Veronika Ballová
(3/2015, Spectrum ) - Biological treatment with monoclonal antibody
MUDr. Andrey Švec, PhD., PharmDr. Andrea Gažová, PhD., prof. PharmDr. Ján Kyselovič, CSc.
(2/2019, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - Criteria of the oncology drugs categorisation process on use of the principle „the value for money“ from the point of view of expected benefits
MVDr., Mgr. Peter Mrva, MPH
(2/2017, Main topic ) - Lymfómové fórum 2010
MUDr. Miriam Ladická
(2/2010, Events ) - Malignant lymphomas of the stomach
MUDr. Ľuboš Drgoňa, CSc.
(3/2011, Review articles ) - Pathology Update, Stockholm 2006
prof. MUDr. Štefan Galbavý, CSc.
(4/2006, Events ) - Ipilimumab in the treatment of malignant melanoma
MUDr. Róbert Godál
(3/2011, Drugs & drug classes ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Treatment and prognosis of patients with hairy cell leukaemia treated in 1996 – 2010 at the National Cancer Institute in Bratislava
MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, MUDr. Radoslav Greksák, PhD., MUDr. Iveta Oravcová, PhD.
(4/2011, Original articles & case reports ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - Správa z 15. kongresu Európskej hematologickej spoločnosti v Barcelone
MUDr. Ľudmila Demitrovičová
(5/2010, Events ) - Role of pathologist in the diagnosis of cancer of unknown primary origin
doc. MUDr. Karol Kajo, PhD.
(4/2013, Main topic ) - CHRONIC LYMPHOCYTIC LEUKEMIA – BIOLOGY, PROGNOSIS AND CLINICAL PICTURES (PART 1)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(5/2008, Review articles ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - XVI. konferencia detských hematológov a onkológov SR a ČR
MUDr. Eva Bubanská, PhD.
(4/2006, Events ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Difúzny veľkobunkový lymfóm z B-lymfocytov – úvodné slovo
Prof. MUDr. Elena Tóthová, CSc
(1/2015, Focus ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Relapsed/refractory diffuse large B-cell lymphoma
MUDr. Miriam Ladická
(4/2015, Spectrum ) - Experience with obinutuzumab in patients with chronic lymphocy
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(6/2017, Original articles & case reports ) - NODULE GOITRE AS THE FIRST SYMPTOM OF NON-HODGKIN LYMPHOMA/B-CLL: FROM THYROID GLAND DISEASE TO BLOOD DISORDER – CASE REPORT
MUDr. Ľubica Váleková, MUDr. Katarína Macháleková, MUDr. Peter Kentoš, MUDr. Mikuláš Pura, MUDr. Peter Szépe, CSc., Ing. Jana Fedorová, MUDr. Peter Vaňuga
(3/2008, Original articles ) - Acute hematologic emergencies in oncology
MUDr. Ľudmila Krištof
(1/2012, Review articles ) - Diffuse large B-cell lymphoma in atypical locations
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2015, Spectrum ) - Childhood acute lymphoblastic leukemia: from genome to patient
doc. MUDr. Alexandra Kolenová, PhD.
(1/2016, Main topic ) - Particularities of non-Hodgkin´s lymphomas in children
MUDr. Ladislav Deák
(1/2016, Main topic ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Antitumor immunity
MUDr. Ján Lakota, CSc., MUDr. Milan Žuffa, CSc.
(2/2015, Review articles ) - THE ROLE AND LIMITS OF PATHOLOGY IN ONCOLOGY
prof. MUDr. Lukáš Plank, CSc.
(1/2006, Review articles ) - Establishing diagnosis of hairy cell leukemia (HCL) and identification of the extent of the minimal residual disease (MRD) with flow cytometry of bone marrow aspirate and immunochemistry of trephine biopsy
MUDr. Radoslav Greksák, PhD.
(6/2012, Original articles & case reports ) - Indolentné B-bunkové non-Hodgkinove lymfómy – úvodné slovo
Prof. MUDr. Elena Tóthová, CSc.
(1/2017, Spectrum ) - Differential diagnostics of pulmonary infiltrative process in a patient with chronic lymphocytic leukemia (CLL) – case report
MUDr. Pavol Hollý, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ivana Plameňová, PhD., MUDr. Ivana Babinská, MUDr. Mária Hladká
(6/2012, Original articles & case reports ) - Úvodné slovo
MUDr. Veronika Ballová
(2/2014, Editorial ) - Biology of malignant lymphomas
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD.
(2/2014, Main topic ) - Diffuse large B-cell lymphoma
MUDr. Andrej Vranovský, PhD., MUDr. Michaela Sojáková
(2/2014, Main topic ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Primary cutaneous lymphomas
MUDr. Miriam Ladická
(2/2014, Main topic ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review ) - Správa z ASH
MUDr. Andrej Vranovský, PhD.
(2/2014, Events ) - Laborathory diagnosis of CLL: cytology, flow cytometry
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD.
(3/2014, Oncohematology Review ) - Initial treatment of chronic lymphocytic leukaemia
MUDr. Emília Flochová, PhD.
(5/2014, Oncohematology Review ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - HODGKIN`S LYMPHOMAS – CURRENT DIAGNOSTICS AND TREATMENT
MUDr. Jan Hudeček, CSc.
(2/2006, Review articles ) - Hepatitis B in the cancer patients treated by chemotherapy
MUDr. Tomáš Šálek, doc. MUDr. Peter Jarčuška, PhD., MUDr. Sylvia Dražilová, MUDr. Marian Oltman, MUDr. Ľubomír Skladaný
(6/2011, Review articles ) - Publikujeme v zahraničí
(1/2018, Information & comments ) - Suplement - Stratégia liečby malígnych lymfómov
(1/2018, online attachment ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles ) - Role of pathologist in the management of chronic lymphocytic leukaemia
MUDr. Tomáš Balhárek, PhD., prof. MUDr. Lukáš Plank, CSc.1
(6/2014, Oncohematology Review )
- NĚKTERÉ POZNATKY Z 66. VÝROČNÍHO MÍTINKU AMERICKÉ DERMATOLOGICKÉ AKADEMIE
doc. MUDr. Karel Ettler, CSc.
(3/2008, Informations ) - PEMPHIGUS ERYTHEMATOSUS
MUDr. Alena Machovcová, MBA, MUDr. Linda Bláhová, MUDr. Vít Campr, doc. MUDr. Lumír Pock, CSc
(3-4/2007, Case reports ) - 37. Reimanove dni s medzinárodnou účasťou Prešov, 24. – 25. september 2009
MUDr. Klára Martinásková, PhD.
(4/2009, Abstracts ) - Merkel cell carcinoma, atypical manifestation
MUDr. Vladimír Bartoš, prof. MUDr. Katarína Adamicová, PhD., MUDr. Juraj Váňa, PhD., MUDr. Boris Babiš, MUDr. Rastislav Johanes
(3/2011, Original articles & Case reports ) - Abstrakty prednášok z 13. ročníka odbornej konferencie Slovenskej dermatovenerologickej spoločnosti – Smrdácke dni 2012
(1/2013, Abstracts ) - Atopic eczema from the perspective of an allergist
MUDr. Martin Fuchs
(3/2014, Interdisciplinary consilium ) - Poznatky ze 70. výročního mítinku Americké akademie dermatologie (San Diego, 15.–20. 3. 2012)
doc. MUDr. Karel Ettler, CSc.
(4/2012, Events )
- Nové liečivá v EÚ registrované v roku 2014 (IV.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3-4/2015, New drugs ) - Pharmacotherapy of inflammatory rheumatic diseases
PharmDr. Tatiana Geročová, PhD.
(2-3/2014, Current pharmacotherapy ) - The biological therapy of patients with rheumatoid arthritis
MUDr. Oľga Lukáčová, PhD., Doc. MUDr. Jozef Lukáč, PhD.
(1/2017, Current pharmacotherapy )
- Varices cruris et femoris ossificantes
prof. MUDr. Július Mazuch, DrSc., prof. MUDr. Katarína Adamicová, PhD., MUDr. Zuzana Červená
(1/2014, Original articles & Case reports )